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Cancers are characterized by several dramatic biological changes. Among the many post-transcriptional regu-
latory mechanisms, microRNAs are known as fine-tune regulators for their transcript silencing ability. Competing 
endogenous RNAs (ceRNAs) are transcripts that share microRNA binding elements and can compete for them, 
thus regulating each other indirectly. ceRNA networks interconnect the regulatory control of different transcript 
classes of the coding and non-coding space and co-operate with other cellular and molecular regulatory mech-
anisms. Altered ceRNA networks are involved in tumor formation and progression as well as in chemoresistance, 
in invasion and in the onset of metastases. The analysis of changes in the balance between ceRNA transcripts 
could offer hints to identify novel pathways for diagnosis, prognosis and therapies in precision medicine in-
terventions. Moreover, the possibility to query highly specific tumor databases, such as TCGA, and to combine 
clinical data, transcript expression and sequence information is allowing to develop specific predictive tools for 
precision medicine.   
1. The ceRNA mechanism and its implications 
Dysregulated transcriptional, post-transcriptional and translational 
programs that could alter dramatically the global gene regulation 
network are common to many cancer types. Key players in post- 
transcriptional regulation of gene expression are microRNAs (miR-
NAs), characterized by their ability to drive RNA silencing Bartel (2009). 
Intriguinly, certain transcript concentrations and molecular conditions 
allow a further modulation of this miRNA-based regulation, since many 
coding and non-coding transcripts can be bound by the same miRNAs. 
Specifically, when transcripts share one or more miRNA Response Ele-
ments (MREs), they can interact with and compete to bind the same 
particular batch of miRNA molecules and, as a consequence, they can 
cross-coordinate each other indirectly Salmena et al. (2011) [Fig. 1]. 
Suppose a situation with a single miRNA: miR-X and two transcripts: 
tr-A and tr-B, which host one miR-X MRE per molecule. miR-X is 
expressed with 2n molecules and the two transcripts with n molecules 
each: in the steady state a 1:1 ratio is reached and all tr-A and tr-B 
molecules are under the repressive action of miR-X. If the expression 
of tr-B has tripled, we now find 3n molecules of tr-B and globally we 
have 4n molecules of transcripts. The increased expression of tr-B leads 
to a new 1:2 ratio: one molecule of miR-X to two molecules of 
transcripts. In this new situation, the miR-X molecules can no longer act 
on all the transcripts’ molecules therefore allowing a partial derepres-
sion of tr-A, without any variation in the transcription rate of tr-A and 
miR-X. 
The involvement, in this cross-talk mechanism, of almost all RNA 
classes of the non-coding space — like long non-coding RNAs (lncRNAs), 
circular RNAs (circRNAs) and pseudo-genes (Ψ-genes) — together with 
protein-coding genes offers an alternative but nonetheless complemen-
tary hypothesis for the role of the huge number of transcribed, but not 
translated, RNAs Poliseno et al. (2010). 
The ceRNA mechanism alters the common conception on miRNA- 
based transcript regulation. Firstly, mRNA 3’ untranslated regions 
(3’UTRs) can modulate in cis their own trascripts by allowing the miRNA 
fine-tuned balance, but also regulate in trans other transcripts by 
sequestering shared miRNAs. Secondly, ceRNAs offer an intriguing 
explanation of some of the unexpected consequences caused by aber-
rantly expressed transcripts. Specifically, a strong overexpression of a 
single miRNA-modulated transcript would be able to sequester a sig-
nificant number of miRNA molecules resulting in a de-repression of 
other miRNA-modulated transcripts. Instead, a down-modulation of a 
single miRNA-tuned transcript would disengage a significant number of 
miRNA molecules thus free to bind to other RNA targets resulting in a 
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hyper-repression of other miRNA-modulated transcripts Cesana et al. 
(2011) [Fig. 2]. 
Several computational biology techniques were applied in order to 
study the workability of the mechanism and its theoretical extent. The 
first mathematical models Ala et al. (2013), Figliuzzi et al. (2013), Bosia 
et al. (2013) put in evidence the optimal range of molecular cross-talk: a 
small variation in the concentration of competing transcripts would 
have the highest effect on the ceRNA network when all the players’ 
concentrations were near equimolarity. 
Subsequent works, combining experimental results and theoretical 
models, raised questions about the possibility to find physiological sit-
uations in which putative ceRNAs are in conditions of equimolarity: 
since the high number of putative miRNA targets, each target would be 
responsible only for a negligible portion of the global number of MREs 
and not sufficient to affect the other targets’ through a competing cross- 
talk Denzler et al. (2014). This objection was addressed invoking the 
hierarchical binding between miRNAs and targets: experimental obser-
vations have highlighted how miRNAs are likely to bind to high-affinity 
sites (following TargetScan Agarwal et al. (2015) classification) when 
miRNAs concentration is at intermediate range and the targets are more 
numerous than miRNAs, implying a low miRNA:target ratio Bosson et al. 
(2014), Denzler et al. (2016). 
Alongside the mathematical models, several ceRNA databases and 
inferring packages have been proposed Wang et al. (2019), Zhang, Liu 
et al. (2019) mainly based on the correlation among putative ceRNAs 
themselves and the anti-correlation among ceRNAs and miRNAs, with 
scoring systems reflecting the assumption that a higher number of 
miRNAs shared between transcripts leads to a stronger mutual 
cross-talk. 
The principles of ceRNA regulation have also been integrated in tools 
used to provide functional characterization for ncRNAs. PseudoFuN, for 
instance, is a database containing some thousands of associations be-
tween genes, Ψ-genes and miRNAs across 32 tumor types, based on 
differential expression and co-expression, useful to uncover novel reg-
ulatory Ψ-genes in specific tumoral contexts Johnson et al. (2019). 
GDCRNATools, a Bioconductor package, uses spongeScan, an improved 
algorithm for MRE prediction in lncRNAs, and provides several down-
stream analyses like functional enrichment and univariate survival 
analysis useful to further characterize and prioritize the key components 
of the regulatory mechanisms Li, Qu et al. (2018). 
2. ceRNAs and cancer 
From the very beginning, ceRNA networks and cancer have been 
linked together. The tumor suppressor PTEN and the oncogene KRAS 
were demonstrated to experience ceRNA influence driven by Ψ-PTEN, 
PTENP1, and Ψ-KRAS, KRAS1P, respectively, in specific prostate cancer 
cell lines Poliseno et al. (2010). Other cancer highly-expressed Ψ-genes 
show involvement in similar networks: OCT4-pg4 and OCT4-pg5, 
Ψ-genes of OCT4, a crucial gene in the regulation and maintenance of 
proliferation and stem cell pluripotency, are found to compete for 
miR-145 and lead to a ceRNA-based over-expression of OCT4 itself in 
hepatocellular carcinoma and endometrial cancer, respectively Wang 
et al. (2013), Bai et al. (2015). 
After evidence deriving mostly from in-silico and in-vitro analysis 
and from solid tumors, an important contribution derived from a diffuse 
large B cell lymphoma in-vivo experiment. Clues for a ceRNA mecha-
nism involving BRAF and Ψ-BRAF brought to the generation of specific 
Dox-inducible engineered mice with the possibility to overexpress the 
full-length murine Ψ-B-Raf, Braf-rs1, its Ψ-CDS or its Ψ-3’UTR. Inter-
estingly, even if with different severity, induced high-expression of the 
Ψ-gene (or its single components) was able to increase levels of BRAF 
and to promote B cell lymphoma, by sequestering specific miRNAs 
shared by both the Ψ-gene and its cognate gene, like miR-134, miR-543 
and miR-653 Karreth et al. (2015). 
The ability of cancer cells to bypass or manage the presence of 
therapies is the result of several cellular and molecular mechanisms used 
to promote their survival and avoid apoptosis Zheng. (2017). For 
instance, in the subset of 786-O-R and ACHN-R renal cancer cells 
characterized by chemoresistance, lncRNA HOX-antisense intergenic 
RNA (HOTAIR), known to regulate chromatin state, is involved in 
sunitinib resistance. More in detail, highly expressed HOTAIR transcript 
sequesters miR-17-5p molecules and thus indirectly de-represses 
Beclin1, an important player in the formation of autophagosomes. In 
this scenario, autophagy of renal cancer cells is enhanced by 
HOTAIR-driven Beclin1 up-regulation and increases chemoresistance Li 
et al. (2020). On the other hand, gemcitabine resistance of pancreatic 
cancer can be reverted by over-expression of the lncRNA growth 
arrest-specific 5 (GAS5). Specifically, in this tumoral context, the 
chemotherapy resistance is promoted by the expression of miR-221. 
Amongst the targets of miR-221, GAS5, when over-expressed, is 
capable of buffering miR-221 molecules. This sponge effect is able to 
Fig. 1. Left panel. Transcript molecules of ceRNA A, harboring multiple miRNA 
Response Elements (MREs) for two different miRNAs, are under the post- 
transcriptional regulation of these miRNAs. Right panel. In the same situation, 
a new ceRNA B, harboring multiple MREs for the same miRNAs too, is tran-
scribed and its molecules can sponge these miRNAs allowing a reduced post- 
transcriptional regulation of ceRNA A by these miRNAs. 
Fig. 2. A schematic representation of the ceRNA modulation mechanism. In 
situation 1, when ceRNA A is over-expressed, the cellular concentration of 
particular miRNA response elements (MREs) increases as well as the number of 
miRNA molecules sponged by ceRNA A, thus reducing their abundance and 
causing a de-repression of ceRNA B expression. In situation 2, the concentration 
of all transcripts allows the repressive regulation of long transcripts by miRNAs 
(whether translational repression or post-transcriptional degradation). In situ-
ation 3, when ceRNA A is down-regulated more miRNAs are freed from ceRNA 
A sponging action and thus allowed to act on and further repress ceRNA 
B expression. 
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reverse miR-221 induced proliferation, migration, 
epithelial-mesenchymal transition (EMT) and chemotherapy resistance 
Liu et al. (2018). 
In leukemias, lncRNAs play a significant role, too. For instance, in 
Acute Myeloid Leukemia (AML), the lncRNA HOXA-AS2 is found highly 
expressed in AML patients after adriamycin treatment and in U/A and T/ 
A ADR (Adverse Drug Reaction) cell lines, implying a possible involve-
ment in the resistance to adriamycin-based chemotherapy. Moreover, 
HOXA-AS2 inhibition suppresses cell proliferation and promotes 
apoptosis. Specifically, high levels of HOXA-AS2 sequester miR-520c-3p 
molecules thus de-repressing S100A4 protein, already known for its 
capacity to promote invasion and metastasis formation in several tu-
mors, including AML. Interestingly, experimental results suggest that 
HOXA-AS2 silencing could affect S100A4 expression, thus reverting 
adriamycin-induced chemoresistance. Therefore, HOXA-AS2-targeted 
therapy could be a promising program in association with adriamycin- 
based chemotherapy Dong et al. (2018). 
Beyond involvement in chemoresistance, several ncRNAs acting as 
ceRNAs have direct associations with metastasis formation and invasion 
too. In Osteosarcoma, metastasis-associated lung adenocarcinoma 
transcript 1 lncRNA (MALAT1) highlights even more the numerous 
biological mechanisms that cancer is able to follow. It is found to act as 
ceRNA impinging on different pathways by competing for several in-
dependent miRNAs: miR-144-3p, miR-34a, miR-34c-5p, miR-449a and 
miR-449b. In particular, osteosarcoma cell lines and osteosarcoma tis-
sues are characterized by a high-expression of MALAT1 and, at the same 
time, a down-modulation of the two miRNA clusters, miR-34a/c-5p and 
miR-449a/b Wang et al. (2017). MALAT1 knockdown is able to suppress 
cell proliferation and metastasis, and among the miRNA targets that 
show a ceRNA cross-talk modulation are the proto-oncogenes c-Met and 
SOX4, both already studied for their involvement in cell migration, in-
vasion, epithelial-mesenchymal transition (EMT) and cancer metastasis. 
In a similar cellular setting, MNNG/HOS osteosarcoma cells, MALAT1 
was proven to sponge miR-144-3p and to promote proliferation and 
metastasis by ceRNA cross-talking with ROCK1/ROCK2. To further 
study the ability of highly expressed MALAT1 to spread metastasis, 
MALAT1-overexpressing MNNG/HOS cells were subcutaneously inocu-
lated into nude mice and, after 6 weeks, lungs presented a high number 
of tumor nodules demonstrating the role of up-regulation of MALAT1 in 
promoting pulmonary metastasis of osteosarcoma Sun et al. (2019). 
lncRNA PVT1 allows to further highlight the complexity of RNA 
molecules involved in ceRNA networks. In normal breast tissues, 
lncRNA PVT1 is part of a specific ceRNA network whereas, in breast 
invasive carcinoma, it ceases to act as ceRNA although significantly up- 
regulated. An intriguing hypothesis for this radical ceRNA rewiring re-
lies on the differential expression of alternative isoforms. Specifically, in 
invasive breast cancer, the PVT1 isoform that hosts the miRNA binding 
sites is subject to a drastic reduction in concentration in favor of other 
isoforms without MREs, thus obtaining the upregulation of the isoform 
which is unable to act as a ceRNA Conte et al. (2017). Moreover, a 
specific circRNA, circ-PVT1, arises from one exon of the lncRNA PVT1. 
The circ-PVT1 harbors MREs for different miRNAs and its activity as a 
ceRNA has been observed in two different contexts: in paclitaxel resis-
tance of gastric cancer cells through the axis ZEB1/miR-124-3p and in 
proliferation and invasion in Non-Small Cell Lung Cancer through the 
E2F2/miR-125b network Liu et al. (2019), Li, Zhang et al. (2018). 
2.1. ceRNAs and clinical perspectives 
These important evidences in several cancer development and drug- 
response steps led to consider the ceRNA mechanism also for diagnosis 
and prognosis: ceRNA networks can thus be used to reveal novel clini-
cally relevant ncRNAs and mRNAs as biomarkers or as possible thera-
peutic targets. 
Moreover, the large amount of clinical and expression data organized 
into TCGA (http://cancergenome.nih.gov/) database, GEO (http 
s://www.ncbi.nlm.nih.gov/geo/) and ArrayExpress (https://www.ebi. 
ac.uk/arrayexpress/) datasets and the NCI’s Genomic Data Commons 
(GDC, https://gdc.cancer.gov/) allowed to increase the scope and ac-
curacy of these predictions Paul et al. (2018). A lung squamous cell 
carcinoma (LUSC) study highlighted the differentially expressed tran-
scripts from several GEO microarray LUSC projects and those from 
TCGA LUSC patients. The good consensus overlap of 129 up- and 
down-modulated transcripts between the array-based and 
sequences-based analyses served as a starting point for the functional 
characterization of both transcripts and associated-proteins. Specif-
ically, a ceRNA network was built up integrating differentially expressed 
coding RNAs, lncRNAs and miRNAs with the GDCRNATools software: 
EZH2, ABCC5, and KIF23 mRNAs were found to be under the putative 
regulation of ceRNA networks and their low expression was associated 
with shorter survival times Li, Gu et al. (2018). 
The same availability of clinical and expression data has also facili-
tated the transition from preclinical association clues toward personal-
ized medicine studies with promising clinical evidence, aiming to 
provide the most accurate individual prognostic knowledge before sur-
gery and enhance the effectiveness of individual treatments. 
In particular, the possibility to build a ceRNA network specific for 
each pathological state — merging information of differentially 
expressed miRNAs, protein-coding genes and ncRNAs according to the 
similarity of their MRE profiles — allowed the development of predic-
tive tools for precision medicine. In colorectal cancer (CRC), a specific 
ceRNA network consisting of 14 lncRNAs, 29 miRNAs, and 79 mRNAs 
was identified. From the same network, a predictive multivariate Cox 
regression model highlighted a signature based on 15 mRNAs as inde-
pendent risk factors for tumor prognosis. Further Kaplan Meier analysis 
confirmed that patients characterized by high expression for this 
signature had significantly poorer overall survival than those with low 
expression. Moreover, two predictive tools for precision medicine were 
proposed: the Smart Cancer Survival Predictive System for on-line 
Overall Survival prediction and the Gene Survival Analysis Screen Sys-
tem to further explore survival curves for specific gender and patho-
logical stage subgroups Zhang, He et al. (2019). 
3. Conclusions 
The ceRNA-based post-transcriptional mechanism has received 
extensive experimental confirmation and its effects have been verified in 
many normal and pathological conditions, from neurodegenerative 
diseases to immune and autoimmune responses, from heart diseases to 
cancers. In principle, basically all cancer types can be subjected to and 
partially driven by the ceRNA mechanism: from solid tumors to leuke-
mias and lymphomas, ceRNA networks show how long and short RNA 
molecules are deeply interconnected and can influence each other. 
Protein-coding transcripts, lncRNAs, pseudo-genes, circRNAs and miR-
NAs are gathered in complex regulatory networks that join other levels 
of transcriptional and post-transcriptional organization, forming multi- 
level networks of interaction and regulation. 
The growing amount of expression and sequence data, interaction 
effects, clinical stratification, available from reference cancer consortia 
such as TCGA, has allowed to investigate the effects of de-regulation and 
reprogramming in specific subsets of patients. 
However, the identification of the ceRNA networks and the explo-
ration of their role are based on two strategies that both suffer from 
limitations. Bioinformatics predictions derive from statistical methods 
and indirect evidence, and in vitro verifications are based on induced 
knockdown and/or overexpression experiments that have a profound 
impact on biological contexts. A great deal of effort is needed to verify 
that the proposed ceRNA networks play an essential role in pathologies. 
Nevertheless, they can provide an alternative starting point to dissect 
the intertwined gene regulatory networks and to discover new molecules 
that can be used as diagnostic, prognostic and therapeutic targets in 
precision medicine interventions. 
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